Cherpes Lab investigators discovered that recombinant ephrin-A3 or agonist ephrin-A3-derived peptides promote expression of cell-cell adhesion molecules in epithelial surfaces and improve epithelial barrier function.
Researchers at Stanford have developed a microparticle-based vaccine that in a single shot enables enhanced activation of CD8+ and/or CD4+ T cells to fight against infectious diseases and cancer.